Artiva Biotherapeutics, Inc. employees and revenue per employee

ARTV · Biotechnology · $203M market cap

Artiva Biotherapeutics, Inc. had 89 employees at the end of fiscal Dec 2024. Revenue for the year was $251,000, or $3K per employee.

Employees

89

Revenue

$251,000

Revenue / employee

$3K

Peer median $457K

Rank in industry

107 of 110

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

Only one fiscal year on file so far, so there is no trend to draw yet.

Employees, last six fiscal years
89'24
Revenue per employee, last six fiscal years
$3K'24

Artiva Biotherapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
STTK
Shattuck Labs, Inc.
40$1.0M$25KContracting
DNTH
Dianthus Therapeutics, Inc.
92$2.0M$22KHiring into decline
ABSI
Absci Corporation
140$2.8M$20KContracting
INBX
Inhibrx Biosciences Inc.
109$1.3M$12KLeaner
NGNE
Neurogene Inc.
107$925,000$9K—
CLDX
Celldex Therapeutics, Inc.
198$1.5M$8KHiring into decline
ARTV
Artiva Biotherapeutics, Inc.
89$251,000$3K—
AVTX
Avalo Therapeutics, Inc.
33$59,000$2KHiring into decline
LYEL
Lyell Immunopharma, Inc.
161$36,000$224Contracting
Every Healthcare company

Questions about Artiva Biotherapeutics, Inc.

How many employees does Artiva Biotherapeutics, Inc. have?
Artiva Biotherapeutics, Inc. reported 89 employees for the fiscal year ending Dec 2024, in the annual report it filed on March 24, 2025.
What is Artiva Biotherapeutics, Inc.'s revenue per employee?
Artiva Biotherapeutics, Inc. brought in $251,000 of revenue in fiscal Dec 2024, which is $3K per employee. That ranks 107 of 110 companies we track in Biotechnology, where the median is $457K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare ARTV with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Artiva Biotherapeutics, Inc.'s annual reports (Form 10-K), latest filed March 24, 2025. This is data, not a recommendation to buy or sell ARTV.